Relieves muscle spasm associated with acute, painful musculoskeletal conditions. ANDA 72854, held by Aiping Pharmaceutical. Cyclobenzaprine Hydrochloride.
As of Nov 21, 2026, ANDA 72854 (Cyclobenzaprine Hydrochloride), held by Aiping Pharmaceutical, was first approved by FDA on Nov 19, 1991, with 14 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Cyclobenzaprine hydrochloride tablets are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 19, 1991 | Original application | Approved |
| Cyclobenzaprine Hydrochloride10MG · tablet;oral | Cyclobenzaprine Hydrochloride | Rx |
| Cyclobenzaprine Hydrochloride5MG · tablet;oral | Cyclobenzaprine Hydrochloride | Rx |
| Cyclobenzaprine Hydrochloride7.5MG · tablet;oral | Cyclobenzaprine Hydrochloride | Rx |
| May 13, 2026 | Supplement 24Manufacturing | Approved | None posted |
| Jul 23, 2015 | Supplement 23Labeling · Standard review | Approved | None posted |
| Feb 3, 2006 | Supplement 14Manufacturing | Approved | None posted |
| Feb 3, 2006 | Supplement 15Labeling | Approved | None posted |
| Jun 28, 2005 | Supplement 12Labeling | Approved | None posted |
| Aug 27, 2001 | Supplement 9Manufacturing | Approved | None posted |
| Jan 21, 2000 | Supplement 8Manufacturing | Approved | None posted |
| May 5, 1999 | Supplement 7Manufacturing | Approved | None posted |
| Feb 5, 1999 | Supplement 4Manufacturing | Approved | None posted |
| Feb 5, 1999 | Supplement 5Labeling | Approved | None posted |
| Feb 5, 1999 | Supplement 6Manufacturing | Approved | None posted |
| Sep 26, 1997 | Supplement 3Manufacturing | Approved | None posted |
| Apr 22, 1994 | Supplement 2Labeling | Approved | None posted |
| Jan 24, 1994 | Supplement 1Manufacturing | Approved | None posted |
| Nov 19, 1991 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters